VivoSim Labs, Inc. Cost of Services, Amortization (Deprecated 2018-01-31)
VivoSim Labs, Inc. (VIVS) reported Cost of Services, Amortization (Deprecated 2018-01-31) of $556.00 thousand for the 9-month period ending 2014-12-31, per its 10-Q filed 2015-02-06.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServicesAmortization · last filed 2015-02-06
- VivoSim Labs, Inc. cost of services, amortization (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $87.00K, a 20.91% decline year-over-year.
- VivoSim Labs, Inc. cost of services, amortization (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $328.00K.
- VivoSim Labs, Inc. cost of services, amortization (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $141.00K, a 95.83% increase year-over-year.
- VivoSim Labs, Inc. cost of services, amortization (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $141.00K, a 45.98% decline year-over-year.
- VivoSim Labs, Inc. cost of services, amortization (deprecated 2018-01-31) for fiscal 2014 was $323.00K.
- VivoSim Labs, Inc. cost of services, amortization (deprecated 2018-01-31) for fiscal 2012 was $556.00K.
| Period end | Cost of Services, Amortization (Deprecated 2018-01-31) 3 month | Cost of Services, Amortization (Deprecated 2018-01-31) 6 month | Cost of Services, Amortization (Deprecated 2018-01-31) 9 month | Cost of Services, Amortization (Deprecated 2018-01-31) 12 month | Cost of Services, Amortization (Deprecated 2018-01-31) 65 month | Cost of Services, Amortization (Deprecated 2018-01-31) 68 month | Cost of Services, Amortization (Deprecated 2018-01-31) 71 month | Cost of Services, Amortization (Deprecated 2018-01-31) 74 month | Cost of Services, Amortization (Deprecated 2018-01-31) 77 month | Cost of Services, Amortization (Deprecated 2018-01-31) 80 month | Cost of Services, Amortization (Deprecated 2018-01-31) 83 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-06 | $415.00K derived: sum of 2 quarters · filed 2015-02-06 | $556.00K 10-Q · filed 2015-02-06 | $697.00K derived: sum of 4 quarters · filed 2015-02-06 | |||||||
| 2014-09-30 | $328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-07 | $469.00K 10-Q · filed 2014-11-07 | $610.00K derived: sum of 3 quarters · filed 2014-11-07 | $720.00K derived: sum of 4 quarters · filed 2015-02-06 | |||||||
| 2014-06-30 | $141.00K 10-Q · filed 2014-08-08 | $282.00K derived: sum of 2 quarters · filed 2014-08-08 | $392.00K derived: sum of 3 quarters · filed 2015-02-06 | $392.00K derived: sum of 4 quarters · filed 2015-02-06 | |||||||
| 2014-03-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | $251.00K derived: sum of 2 quarters · filed 2015-02-06 | $251.00K derived: sum of 3 quarters · filed 2015-02-06 | $323.00K 10-K · filed 2014-06-10 | $1.14M 10-K · filed 2014-06-10 | ||||||
| 2013-12-31 | $110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-06 | $110.00K derived: sum of 2 quarters · filed 2015-02-06 | $182.00K 10-Q · filed 2015-02-06 | $443.00K derived: sum of 4 quarters · filed 2015-02-06 | $999.00K 10-Q · filed 2014-02-06 | ||||||
| 2013-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-07 | $72.00K 10-Q · filed 2014-11-07 | $333.00K derived: sum of 3 quarters · filed 2014-11-07 | $853.00K derived: sum of 4 quarters · filed 2014-11-07 | $890.00K 10-Q · filed 2013-11-08 | ||||||
| 2013-06-30 | $72.00K 10-Q · filed 2014-08-08 | $333.00K derived: sum of 2 quarters · filed 2014-08-08 | $853.00K derived: sum of 3 quarters · filed 2014-08-08 | $889.00K 10-Q · filed 2013-08-09 | |||||||
| 2013-03-31 | $261.00K 10-K · filed 2014-06-10 | $781.00K derived: sum of 2 quarters · filed 2014-06-10 | $817.00K 10-KT · filed 2013-05-24 | ||||||||
| 2012-12-31 | $520.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | $556.00K 10-Q · filed 2014-02-06 | $556.00K 10-K · filed 2014-06-10 | $556.00K 10-K · filed 2013-03-15 | |||||||
| 2012-09-30 | $36.00K 10-Q · filed 2013-11-08 | $36.05K 10-Q · filed 2012-11-14 | $36.05K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |